Statins, fibrates, and venous thromboembolism: a meta-analysis

Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs

(2009) Ferhana Y. Ali et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A new indication for statins to prevent venous thromboembolism? Not yet

(2009) M. CUSHMAN   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study

(2009) H. T. SØRENSEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

(2009) Robert J. Glynn et al.   NEW ENGLAND JOURNAL OF MEDICINE

HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis

(2008) A. S. RAMCHARAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cardiovascular Risk Factors and Venous Thromboembolism

(2007) Walter Ageno et al.   CIRCULATION

Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: Role of drug induced homocysteinemia?

(2007) Karine Lacut et al.   THROMBOSIS RESEARCH